International Cancer Imaging Society


Welcome !

Message from the President

"Welcome to the International Cancer Imaging Society (ICIS), a professional body established to promote education and stimulate research in oncological imaging. ICIS promotes the exchange of ideas among radiologists and other physicians who specialize in cancer imaging. We hold our annual meetings at various locations in Europe, and satellite meetings are periodically conducted abroad in conjunction with national societies; past venues have included Hong Kong, South Africa, Kuwait, Hungary and Brazil. In February 2013 we held our inaugural one day, personalised, interactive teaching course in London, Masterclass in Imaging of Gynaecological Cancers. This was a great success and we hope to repeat the course in the future. The 13th ICIS Annual Teaching Course will be held in York, UK, from September 30 - October 2, 2013 - do join us if you can!

I invite you to JOIN ICIS and become a Society member. You will benefit from reduced registration fees at all ICIS meetings and gain full access to the Society's online journal CANCER IMAGING. Your membership and participation in the Society will help to further invigorate this exciting field of clinical practice and research."
 

 

Next Society meeting

Society Meeting and 13th Annual Teaching Course

Mon 30 Sep 2013 Wed 02 Oct 2013 Society

Society Meeting and 13th Annual Teaching Course

York, UK

Highlighting the role of imaging in the multidisciplinary management of oncology patients through:

  • Practical problem solving
  • Interactive teaching and active learning
  • Illustration of novel imaging techniques
  • Presentation of innovative research

Registration and full programme available now.

» More Meetings
 

News

15 April 2013

International Cancer Imaging Society Update - Press Release

Registration is now open for the ICIS Society Annual Teaching Course. This year’s course will be held in the historic city of York, UK, from Monday 30th September until Wednesday 2nd October. ...

» Read more » Other news items
 

ICIS Current and Past Office Bearers

Dr. Leslie Quint
Dr. Leslie Quint - President
Prof. Andrea Rockall
Prof. Andrea Rockall - President Elect
Dr. Jay Heiken
Dr. Jay Heiken - Secretary
Dr. Dow-Mu Koh
Dr. Dow-Mu Koh - Treasurer
Prof. Anwar Padhani
Prof. Anwar Padhani - Immediate Past President
Prof. Vincent Chong
Prof. Vincent Chong - Past President
Dr. Liliane Ollivier
Dr. Liliane Ollivier - Past President
Professor Wolfgang Schima
Professor Wolfgang Schima - Past President
Prof. Robert Hermans
Prof. Robert Hermans - Past President
Dr. Sheila Rankin
Dr. Sheila Rankin - Past President
Prof. Jelle Barentsz
Prof. Jelle Barentsz - Past President
Prof. Massimo Bellomi
Prof. Massimo Bellomi - Past President
Prof. Daniel Vanel
Prof. Daniel Vanel - Past President
Prof. Rodney Reznek
Prof. Rodney Reznek - Past President
Prof. Dame Janet Husband DBE
Prof. Dame Janet Husband DBE - Past President
Ken Miles
Ken Miles - Editor, Cancer Imaging
Dr. Conor Collins
Dr. Conor Collins - Past Honorary Secretary
Prof. Dr. med Stefan Diederich
Prof. Dr. med Stefan Diederich - Past Honorary Secretary
Dr. Michael King
Dr. Michael King - Past Honorary Treasurer
Maureen Watts
Maureen Watts - General Manager


» Full list of ICIS Fellows


ICIS 2013 Registration

Registration for ICIS 2013 in York is now open !.


Members Area


Help

From now on, please log into the Member's area using your e-mail address and password. If you have problems, then get in touch with us using the Contact Us page.

When changing your password, please note that your change may take up to 24 hours to synchronise with the Cancer Imaging site.

Cancer / Oncology News From Medical News Today

Epigenetic Regulators And NF-Kappa B May One Day Be Targeted For The Treatment Of Cancer

Published: Wed, 22 May 2013 07:00:00 GMT

In a new study described in the journal Oncogene, researchers reveal how a key player in cell growth, immunity and the inflammatory response can be transformed into a primary contributor to tumor growth. Scientists call this Jekyll-and-Hyde molecule NF-kappa B. In healthy cells, it is a powerful "first responder," a vital part of the body's immune and inflammatory responses...

Software May Allow Doctors To Track Progression Of Cancer, Response To Treatment, And Risk Of Relapse

Published: Tue, 21 May 2013 08:00:00 GMT

In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual cells. These technologies have led to new challenges, however, as scientists now struggle with how to make sense of the resulting trove of data. Now a solution may be at hand...

Outcome In Head And Neck Cancer Predicted By Genetic Diversity Within Tumors

Published: Tue, 21 May 2013 08:00:00 GMT

A new measure of the heterogeneity - the variety of genetic mutations - of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer...

Cancer Survivors Suffer Physical & Emotional Impairments Which Often Go Untreated

Published: Tue, 21 May 2013 07:00:00 GMT

A new review finds cancer survivors suffer a diverse and complex set of impairments, affecting virtually every organ system. Writing in CA: A Cancer Journal for Clinicians, Julie Silver, M.D...

UK Aims To Make Genetic Testing Available To All Cancer Patients

Published: Tue, 21 May 2013 07:00:00 GMT

A research program that should eventually allow all cancer patients to have access to genetic testing has been launched with £2.7 million ($4 million) funding from the Wellcome Trust...

Depressive Symptoms Are Linked To Early Death In Cancer Survivors

Published: Mon, 20 May 2013 07:00:00 GMT

Depressed cancer survivors are twice as likely to die prematurely than those who do not suffer from depression, irrespective of the cancer site. That's according to a new study, by Floortje Mols and colleagues, from Tilburg University in The Netherlands. Their work is published online in Springer's Journal of Cancer Survivorship...

Non-Surgical Treatments For Multiple Tumors Move One Step Closer

Published: Sun, 19 May 2013 07:00:00 GMT

A study led by researchers from Plymouth University Peninsula Schools of Medicine and Dentistry has for the first time revealed how the loss of a particular tumour suppressing protein leads to the abnormal growth of tumours of the brain and nervous system. The study is published in Brain: A Journal of Neurology...

Study Finds Broad Support For Rationing Of Some Types Of Cancer Care

Published: Sat, 18 May 2013 07:00:00 GMT

The majority of cancer doctors, patients, and members of the general public support cutting health care costs by refusing to pay for drugs that don't improve survival or quality of life, according to results of a new study that will be presented by researchers from the Perelman School of Medicine at the University of Pennsylvania during the annual meeting of the American Societ...

Advanced Prostate Cancer Drug Xofigo Approved By FDA

Published: Fri, 17 May 2013 12:00:00 GMT

Xofigo (radium Ra 223 dichloride) has been approved by the US FDA for symptomatic late-stage (metastatic) castration-resistant prostate cancer that has reached bones but not other organs, i.e. with no known visceral metastatic disease. The Food and Drug Administration (FDA) approved Xifogo under the priority review program, three months ahead of schedule...

Study Suggests Cutaneous Squamous Cell Carcinoma Carries Risk Of Metastasis And Death

Published: Fri, 17 May 2013 09:00:00 GMT

JAMA Dermatology Study Highlights A study by Chrysalyne D. Schmults, M.D., M.S.C.E., of Brigham and Women's Hospital, Boston, and colleagues suggests cutaneous squamous cell carcinoma (CSCC) carries a low but significant risk of metastasis and death. The ten-year retrospective cohort study was conducted at an academic medical center in Boston, and included 985 patients with 1,832 tumors...


Subscribe to our mailing list

* indicates required
Email Format